Page last updated: 2024-08-23

zidovudine and Hepatoblastoma

zidovudine has been researched along with Hepatoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brandt, S; Grote, J; Heller, H; Schuster, KD	1

Other Studies

1 other study(ies) available for zidovudine and Hepatoblastoma

Article	Year
Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity. Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:1 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Physiological Phenomena; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Hepatoblastoma; Humans; Liver Neoplasms; Reverse Transcriptase Inhibitors; Tamoxifen; Telomerase; Time Factors; Zidovudine	2004

Article

Year

Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity.

Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:1

Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Physiological Phenomena; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Hepatoblastoma; Humans; Liver Neoplasms; Reverse Transcriptase Inhibitors; Tamoxifen; Telomerase; Time Factors; Zidovudine

2004